COVID Vaccine Label Controversy Shows Government Should Not Be the Sole Source of Public Health Guidance
Source: https://www.facebook.com/americanspectator/. "Investigation Finds FDA May Have Covered Up COVID Vaccine Risk for Kids | The American Spectator | USA News and Politics." October 22, 2026. spectator.org
The Gist
The author argues that the FDA seems to be sitting on internal findings about possible child deaths linked to COVID vaccines, and that both political parties have reasons to downplay vaccine risks. Because government health agencies can't be fully trusted to be neutral, she says we should draw on several sources of medical advice instead of just one, and that this competition would force more openness.
Conclusion
Americans and their doctors should not rely solely on government agencies for public health recommendations; they should weigh government and private-institution guidance alongside individual health needs, and competition among sources would improve transparency and decision-making.
Premises
- FDA safety officers compiled a list of children possibly killed by COVID vaccines and recommended updating vaccine labels to reflect fatal outcomes, yet the labels have not been updated ten months later.
- Warning patients about even rare complications is standard practice, and the small number of probable or possible deaths (10, later trimmed to 7) does not justify withholding a label update.
- Former FDA leaders say they reviewed the same cases and reached different conclusions, but if so the review should be published rather than withheld.
- Both the Trump and Biden administrations have political incentives to avoid admitting that the COVID vaccines were less safe than advertised, since each promoted or fast-tracked them.
- Public trust in health institutions tracks partisan agreement with those in charge, which undermines the credibility of government as a neutral source of medical information.
- Competition among multiple sources of recommendations would encourage each to publish its data and evidence, working like a second medical opinion.
Assumptions
- The FDA's failure to update labels reflects possible concealment or political motivation rather than legitimate scientific disagreement about causation.
- Unpublished internal analyses of possible vaccine deaths would be informative and reliable enough to warrant label changes.
- Political incentives to avoid admitting error actually influence FDA and CDC decisions.
- Private institutions are less biased, or at least provide a useful counterweight to government sources.
- Laypeople and their doctors can competently evaluate competing recommendations.
- Partisan-correlated trust in institutions implies the institutions are actually biased, not just distrusted.